Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

TheraVision Ultrasound Ablation System and ACOUSTx Applicators

N.º K: K150019 · 2016-01-13

SolicitanteAcoustic Medsystems, Inc.
Fecha de decisión2016-01-13
Código de productoNTB
Comité asesorSU
DecisiónSubstantially Equivalent

Resumen del dispositivo

TheraVision Ultrasound Ablation System and ACOUSTx Applicators is the device name listed in this FDA 510(k) record. The listed applicant is Acoustic Medsystems, Inc.. It received FDA 510(k) clearance on 2016-01-13 under 510(k) number K150019. The device is classified under product code NTB. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the TheraVision Ultrasound Ablation System and ACOUSTx Applicators?

TheraVision Ultrasound Ablation System and ACOUSTx Applicators is a medical device that received FDA 510(k) clearance on 2016-01-13. The listed applicant is Acoustic Medsystems, Inc.. The 510(k) number is K150019.

When did TheraVision Ultrasound Ablation System and ACOUSTx Applicators receive FDA 510(k) clearance?

TheraVision Ultrasound Ablation System and ACOUSTx Applicators received FDA 510(k) clearance on 2016-01-13, under 510(k) number K150019.

Who is the listed applicant for TheraVision Ultrasound Ablation System and ACOUSTx Applicators?

The FDA 510(k) record lists Acoustic Medsystems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TheraVision Ultrasound Ablation System and ACOUSTx Applicators?

The FDA product code for TheraVision Ultrasound Ablation System and ACOUSTx Applicators is NTB.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑